Etripamil Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MSP-2017

Pipeline

Phase 3: 1

Top Sponsors

Milestone Pharmaceuticals Inc.1

Indications

Heart Disease1
Atrial Fibrillation1

Haddon Heights, New Jersey1 trial

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Cardiovascular Associates Of The Delaware Valley

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.